Global Pholcodine (CAS 509-67-1) Market Size, Growth Analysis and Forecast Insights
Report ID : 1350712 | Published : May 2025 | Study Period : 2023-2033 | Format : PDF + Excel
The market size of the Pholcodine (CAS 509-67-1) Market is categorized based on Formulation Type (Syrups, Tablets, Lozenges, Inhalers, Others) and End-User (Hospitals, Pharmacies, Online Pharmacies, Drug Stores, Others) and Distribution Channel (Direct Sales, Wholesale, Retail, E-commerce, Others) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).
The Pholcodine (CAS 509-67-1) Market size was valued at $300 million in 2023 and is projected to reach $500 million by 2033, growing at a CAGR of 5.2% from 2024 to 2033. This report includes various market segments and analyzes the key trends and factors influencing market growth.
Pholcodine, a proprietary antitussive with a CAS number of 509-67-1, has received substantial focus from the pharmacies because of its effectiveness in managing cough symptoms. As a centrally acting cough suppressant, Pholcodine works by suppressing the cough reflex in the upper central nervous system, or the brain, which makes it favorable for dry cough formulations in both OTC and prescription medicines. Cough medicines containing Pholcodine are in demand all over the world because of its wide range of beneficial properties which makes it an integral part of cough treatment formulations.
In market of Pholcodine, we have rapid changes taking place affected by a wide range of regulatory policies, changing marketing strategies, and new pharmaceutical technology. The number of respiratory diseases is on the increase which together with the need for self treatment will further strengthen demand for Pholcodine products. Increased marketing activities focused on market penetration will improve demand and sales which will also be aided by the current R&D programs aimed at improving the effectiveness and safety of these products. There is a huge opportunity for Pholcodine stakeholders to capitalize on the growing demand by analyzing the marketing strategies, competition, and consumer research which impacts the Pholcodine market in the B2B pharmaceutical market.
| ATTRIBUTES | DETAILS |
| STUDY PERIOD | 2023-2033 |
| BASE YEAR | 2023 |
| FORECAST PERIOD | 2024-2033 |
| HISTORICAL PERIOD | 2023-2024 |
| UNIT | VALUE (USD BILLION) |
| KEY COMPANIES PROFILED | GlaxoSmithKline, Sanofi, Pfizer, Boehringer Ingelheim, AstraZeneca, Johnson & Johnson, Teva Pharmaceuticals, Mylan, Novartis, Bristol-Myers Squibb, Reckitt Benckiser |
| SEGMENTS COVERED |
By Formulation Type - Syrups, Tablets, Lozenges, Inhalers, Others
By End-User - Hospitals, Pharmacies, Online Pharmacies, Drug Stores, Others
By Distribution Channel - Direct Sales, Wholesale, Retail, E-commerce, Others
By Geography - North America, Europe, APAC, Middle East Asia & Rest of World. |
Pholcodine (CAS 509-67-1) Market Dynamics
The Pholcodine (CAS 509-67-1) Market is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.
Market Drivers
- Technological Advancements
- Increasing Consumer Demand
- Regulatory Support
- Globalization
Market Restraints
- High Operational Costs
- Regulatory Challenges
- Market Saturation
Market Opportunities
- Emerging Markets
- Product Innovation
- Strategic Partnerships
Market Challenges
- Technological Disruptions
- Supply Chain Issues
- Changing Consumer Preferences
Pholcodine (CAS 509-67-1) Market Segmentations
Market Breakup by Formulation Type
- Overview
- Syrups
- Tablets
- Lozenges
- Inhalers
- Others
Market Breakup by End-User
- Overview
- Hospitals
- Pharmacies
- Online Pharmacies
- Drug Stores
- Others
Market Breakup by Distribution Channel
- Overview
- Direct Sales
- Wholesale
- Retail
- E-commerce
- Others
Market Breakup by Region
North America
- United States of America
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Players in the Pholcodine (CAS 509-67-1) Market
This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.
- GlaxoSmithKline
- Sanofi
- Pfizer
- Boehringer Ingelheim
- AstraZeneca
- Johnson & Johnson
- Teva Pharmaceuticals
- Mylan
- Novartis
- Bristol-Myers Squibb
- Reckitt Benckiser
Customization Options
Verified Industry Insights offers one of the following report customization options to our respectable clients :
Company Profiling
● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)
Competitive Benchmarking
● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research
Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439
© 2024 Verified Industry Insights. All Rights Reserved